The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 5.6% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (13 analysts) rates it strong buy, with a mean price target of $18.
China Overseas Land & Investment Limited
0688.HK · UNKNOWN · USD · Market cap $136.0B
China Overseas Land & Investment Limited, an investment holding company, engages in the property development, commercial property operations, and other businesses in the People's Republic of China, the United Kingdom, and Macau.
PASS · Titan EthicalScreen close, 2026-09-22 · not a live quote
Last reviewed 13 days ago
Screened 2026-09-22 · the tape above runs as of 11:17 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 12.43 against the desk's fair-value range, base estimate 20.88, over the last year.
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
China Overseas Land & Investment Limited holds its Accumulation at $12.43. Consolidating, no directional conviction, held for 23 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 23 days |
| Price at the screen | $12.43 |
| Valuation | 10.53 trailing · 8.57 forward price to earnings |
| Values screen | PASS |
| Beta | 0.58 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 27.05% | Below 33% | Interest-bearing debt is just 27.1% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 11.61% | Below 49% | Money owed to the company is 11.6% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.67% | Below 5% | Only 0.7% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
China Overseas Land & Investment clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 27%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-22 screen. The gold marker is the market price at the same screen. A 68.0% margin of safety to the base estimate.
Third-party analyst targets: 13 covering, consensus Strong Buy. The average target sits +49% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-22 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 8.6xcheap for a company growing this fast |
| Trailing P/E | 10.5xreasonably valued |
| EPS, trailing | 1.18 |
| EPS, forward | 1.45 |
| Revenue growth | +17.3%steady growth |
| Profit margin | 6.1%thin but positive margins |
| Return on equity | 2.8%a modest return on shareholder capital |
| FCF yield | 0.96% |
| Debt to equity | 0.56moderate, manageable leverage |
| Current ratio | 2.42comfortably covers its short-term bills |
| Beta | 0.58steadier than the market |
| 52-week range | 11.36 - 16.70 |
| Moat | MODERATE |
| Market cap | $136.0B |
The risks · The things to watch: its business and earnings are exposed to Hong Kong and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade0688.HK trades on UNKNOWN (the company is based in Hong Kong). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.9% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (13 analysts) rates it strong buy, with a mean price target of $18.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.4% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (13 analysts) rates it strong buy, with a mean price target of $18.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 14.1% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (13 analysts) rates it strong buy, with a mean price target of $18.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (13 analysts) rates it strong buy, with a mean price target of $18.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 5 Cheap REITs With Dividends Above 3% to Buy on the Dip Zacks · 18d ago
- China Overseas Land & Investment Ltd's Dividend Analysis GuruFocus.com · 18d ago
- China Overseas Land & Investment (SEHK:688) Stock Could Be Undervalued On Earnings Power Simply Wall St. · 20d ago
- China Overseas Land & Investment (SEHK:688): Assessing Valuation After Recent Share Price Rebound Simply Wall St. · 11 Sep 2025
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $16.37 | -4.8% | · | $952 | -4.8% |
| 2 months | $11.93 | +30.6% | · | $1,306 | +30.6% |
| 3 months | $12.90 | +20.8% | · | $1,208 | +20.8% |
| 6 months | $12.73 | +22.4% | · | $1,224 | +22.4% |
| 1 year | $13.03 | +19.6% | $0.55 | $1,238 | +23.8% |
| 2 years | $13.93 | +11.8% | $1.30 | $1,212 | +21.2% |
| 3 years | $15.35 | +1.5% | $2.05 | $1,149 | +14.9% |
| 5 years | $15.25 | +2.2% | $4.39 | $1,310 | +31.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever 0688.HK does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.